Table 2.

Lesion characteristics and clinical outcomes.

	All Patients N = 124	Healing in 6-M Group N = 61	Non-Healing in 6-M Group N = 63	P value
Aortoiliac lesion, N (%)	9 (7.3%)	1 (1.6%)	8 (12.7%)	.033
TASC II classification				1.000
TASC C	2 (22.2%)	0 (0%)	2 (25%)
TASC D	7 (77.8%)	1 (100%)	6 (75%)
CTO	4 (3.2%)	1 (1.6%)	3 (4.8%)	.619
Vessel calcification∗				.268
Grade 2	2 (22.2%)	0 (0%)	2 (25%)
Grade 3	3 (33.3%)	0 (0%)	3 (37.5%)
Femoropopliteal lesion, N (%)	76 (61.3%)	33 (54.1%)	43 (68.3%)	.152
TASC II classification				.978
TASC C	22 (28.9%)	9 (27.3%)	13 (30.2%)
TASC D	46 (60.5%)	20 (60.6%)	26 (60.5%)
CTO	22 (17.7%)	13 (21.3%)	9 (14.3%)	.430
Vessel calcification				.745
Grade 3	17 (13.7%)	8 (13.1%)	9 (14.3%)
Grade 4	21 (16.9%)	9 (14.8%)	12 (19%)
Infra-popliteal lesion N (%)	120 (96.8%)	60 (98.4%)	60 (95.2%)	.619
TASC II classification				.768
TASC C	36 (29%)	17 (27.9%)	19 (30.2%)
TASC D	70 (56.4%)	34 (55.7%)	36 (57.1%)
CTO	101 (81.5%)	51 (83.6%)	50 (79.4%)	.707
Vessel calcification				.299
Grade 3	17 (13.7%)	7 (11.5%)	10 (15.9%)
Grade 4	27 (21.8%)	12 (19.7%)	15 (23.8%)
Run-off vessel numbers (0/1/2/3), N
Before EVT	31/40/37/14	16/16/21/8	15/24/16/6	.459
After EVT	1/28/63/30	0/9/35/17	1/19/28/13	.117
Median run-off vessel numbers, N
Before EVT	1.0 (0–2)	1.0 (0–2)	1.0 (0.5–2)	.447
After EVT	2.0 (2–2.3)	2.0 (2–3)	2.0 (1–2)	.050
Occlusion of plantar arch, N (%)	46 (38.7%)	20 (33.3%)	26 (44.1%)	.311
Procedure success	113 (91.1%)	57 (93.4%)	56 (88.9%)	.565
Stenting	42 (33.9%)	15 (24.6%)	27 (42.9%)	.050
Drug coating balloon
Femoropopliteal	19 (15.3%)	7 (11.5%)	12 (19.0%)	.357
Infra-popliteal	19 (15.3%)	11 (18.0%)	8 (12.7%)	.565
18-month clinical outcome
Target Lesion  Revascularization	18 (14.5%)	9 (14.8%)	9 (14.3%)	1.000
All-cause mortality	29 (23.4%)	8 (13.1%)	21 (33.3%)	.014